145 related articles for article (PubMed ID: 34191362)
1. CyDisCo production of functional recombinant SARS-CoV-2 spike receptor binding domain.
Prahlad J; Struble LR; Lutz WE; Wallin SA; Khurana S; Schnaubelt A; Broadhurst MJ; Bayles KW; Borgstahl GEO
Protein Sci; 2021 Sep; 30(9):1983-1990. PubMed ID: 34191362
[TBL] [Abstract][Full Text] [Related]
2. Multivalent Display of SARS-CoV-2 Spike (RBD Domain) of COVID-19 to Nanomaterial, Protein Ferritin Nanocages.
Kalathiya U; Padariya M; Fahraeus R; Chakraborti S; Hupp TR
Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33671255
[TBL] [Abstract][Full Text] [Related]
3. Targeted intracellular degradation of SARS-CoV-2 via computationally optimized peptide fusions.
Chatterjee P; Ponnapati M; Kramme C; Plesa AM; Church GM; Jacobson JM
Commun Biol; 2020 Nov; 3(1):715. PubMed ID: 33230174
[TBL] [Abstract][Full Text] [Related]
4. Structural basis of severe acute respiratory syndrome coronavirus 2 infection.
Ge J; Zhang S; Zhang L; Wang X
Curr Opin HIV AIDS; 2021 Jan; 16(1):74-81. PubMed ID: 33186231
[TBL] [Abstract][Full Text] [Related]
5. A Bacterial Cell-Based Assay To Study SARS-CoV-2 Protein-Protein Interactions.
Springstein BL; Deighan P; Grabe GJ; Hochschild A
mBio; 2021 Dec; 12(6):e0293621. PubMed ID: 34781739
[TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution.
Zahradník J; Marciano S; Shemesh M; Zoler E; Harari D; Chiaravalli J; Meyer B; Rudich Y; Li C; Marton I; Dym O; Elad N; Lewis MG; Andersen H; Gagne M; Seder RA; Douek DC; Schreiber G
Nat Microbiol; 2021 Sep; 6(9):1188-1198. PubMed ID: 34400835
[TBL] [Abstract][Full Text] [Related]
7. Disulfide Bonds Play a Critical Role in the Structure and Function of the Receptor-binding Domain of the SARS-CoV-2 Spike Antigen.
Grishin AM; Dolgova NV; Landreth S; Fisette O; Pickering IJ; George GN; Falzarano D; Cygler M
J Mol Biol; 2022 Jan; 434(2):167357. PubMed ID: 34780781
[TBL] [Abstract][Full Text] [Related]
8. In silico studies on the comparative characterization of the interactions of SARS-CoV-2 spike glycoprotein with ACE-2 receptor homologs and human TLRs.
Choudhury A; Mukherjee S
J Med Virol; 2020 Oct; 92(10):2105-2113. PubMed ID: 32383269
[TBL] [Abstract][Full Text] [Related]
9. Expression and functional identification of recombinant SARS-CoV-2 receptor binding domain (RBD) from
Gao X; Peng S; Mei S; Liang K; Khan MSI; Vong EG; Zhan J
Prep Biochem Biotechnol; 2022; 52(3):318-324. PubMed ID: 34187304
[TBL] [Abstract][Full Text] [Related]
10. The Nuts and Bolts of SARS-CoV-2 Spike Receptor-Binding Domain Heterologous Expression.
Maffei M; Montemiglio LC; Vitagliano G; Fedele L; Sellathurai S; Bucci F; Compagnone M; Chiarini V; Exertier C; Muzi A; Roscilli G; Vallone B; Marra E
Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944456
[TBL] [Abstract][Full Text] [Related]
11. Enhanced binding of the N501Y-mutated SARS-CoV-2 spike protein to the human ACE2 receptor: insights from molecular dynamics simulations.
Luan B; Wang H; Huynh T
FEBS Lett; 2021 May; 595(10):1454-1461. PubMed ID: 33728680
[TBL] [Abstract][Full Text] [Related]
12. Scanning the RBD-ACE2 molecular interactions in Omicron variant.
Rath SL; Padhi AK; Mandal N
Biochem Biophys Res Commun; 2022 Feb; 592():18-23. PubMed ID: 35007846
[TBL] [Abstract][Full Text] [Related]
13. Landscape of SARS-CoV-2 spike protein-interacting cells in human tissues.
Zheng B; Yuan M; Ma Q; Wang S; Tan Y; Xu Y; Ye J; Gao Y; Sun X; Yang Z; Xu P; Kong L; Wu X; Xu Q
Int Immunopharmacol; 2021 Jun; 95():107567. PubMed ID: 33756225
[TBL] [Abstract][Full Text] [Related]
14. Diversity of ACE2 and its interaction with SARS-CoV-2 receptor binding domain.
Low-Gan J; Huang R; Kelley A; Jenkins GW; McGregor D; Smider VV
Biochem J; 2021 Oct; 478(19):3671-3684. PubMed ID: 34558627
[TBL] [Abstract][Full Text] [Related]
15. Differential Interactions between Human ACE2 and Spike RBD of SARS-CoV-2 Variants of Concern.
Kim S; Liu Y; Lei Z; Dicker J; Cao Y; Zhang XF; Im W
J Chem Theory Comput; 2021 Dec; 17(12):7972-7979. PubMed ID: 34856802
[TBL] [Abstract][Full Text] [Related]
16. A Multi-Disulfide Receptor-Binding Domain (RBD) of the SARS-CoV-2 Spike Protein Expressed in
Brindha S; Kuroda Y
Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163624
[TBL] [Abstract][Full Text] [Related]
17. Insect cell expression and purification of recombinant SARS-COV-2 spike proteins that demonstrate ACE2 binding.
Struble LR; Smith AL; Lutz WE; Grubbs G; Sagar S; Bayles KW; Radhakrishnan P; Khurana S; El-Gamal D; Borgstahl GEO
Protein Sci; 2022 May; 31(5):e4300. PubMed ID: 35481636
[TBL] [Abstract][Full Text] [Related]
18. Molecular dynamic simulation analysis of SARS-CoV-2 spike mutations and evaluation of ACE2 from pets and wild animals for infection risk.
Chen P; Wang J; Xu X; Li Y; Zhu Y; Li X; Li M; Hao P
Comput Biol Chem; 2022 Feb; 96():107613. PubMed ID: 34896769
[TBL] [Abstract][Full Text] [Related]
19. Identification of SARS-CoV-2 Receptor Binding Inhibitors by In Vitro Screening of Drug Libraries.
David AB; Diamant E; Dor E; Barnea A; Natan N; Levin L; Chapman S; Mimran LC; Epstein E; Zichel R; Torgeman A
Molecules; 2021 May; 26(11):. PubMed ID: 34072087
[TBL] [Abstract][Full Text] [Related]
20. Molecular basis for higher affinity of SARS-CoV-2 spike RBD for human ACE2 receptor.
Delgado JM; Duro N; Rogers DM; Tkatchenko A; Pandit SA; Varma S
Proteins; 2021 Sep; 89(9):1134-1144. PubMed ID: 33864655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
